ADXS stock news

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces the Read more
Conestoga Capital Advisors Llc decreased Aaon Inc (AAON) stake by 26.08% reported in 2018Q4 SEC filing. Conestoga Capital Advisors Llc sold 581,639 shares as Aaon Inc (AAON)’s stock rose 9.00%. The Read more

Will Advaxis Continue to Surge Higher?

01:45pm, Friday, 29'th Mar 2019
As of late, it has definitely been a great time to be an investor in Advaxis. Read more

Will Advaxis Continue to Surge Higher?

01:45pm, Friday, 29'th Mar 2019
As of late, it has definitely been a great time to be an investor in Advaxis. Read more
Both Melinta Therapeutics Inc. (NASDAQ:MLNT) and Advaxis Inc. (NASDAQ:ADXS) are Biotechnology companies, competing one another. We will compare their analyst recommendations, profitability, risk, divi Read more
Advaxis, Inc. announces the presentation of ADXS-NEO data in a poster discussion entitled “Safety and Immunogenicity of a Personalized Neoantigen-Listeria Vaccine in Cancer Patients” at the Americ Read more

Advaxis Inc. (ADXS) Plunges 14.54% on March 28

09:11pm, Thursday, 28'th Mar 2019
Advaxis Inc. ( ADXS ) had a rough trading day for Thursday March 28 as shares tumbled 14.54%, or a loss of $-0.0655 per share, to close at $0.39. After opening the day at $0.45, shares of Advaxis Inc. Read more
Nasdaq-listed late-stage biotech firm Advaxis, Inc. (NASDAQ:ADXS) focusses on discovery, development, and commercialization of immunotherapy products. The latest from this company is its announcement Read more
In deep diving into the profits for Advaxis, Inc. (NasdaqGS:ADXS) we can see that the trailing 12 months net profit growth stands at -0.65713. The calculation for this number is as follows: 1yr Growth Read more
This is therefore a contrasting of the analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation in Advaxis Inc. Read more
Both Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) and Advaxis Inc. (NASDAQ:ADXS) are each other’s competitor in the Biotechnology industry. Thus the contrast of Read more
This is a contrast between NuCana plc (NASDAQ:NCNA) and Advaxis Inc. (NASDAQ:ADXS) based on their dividends, analyst recommendations, profitability, Read more
Fortress Biotech Inc. (NASDAQ:FBIOP) and Advaxis Inc. (NASDAQ:ADXS), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the instituti Read more
As Biotechnology businesses, Therapix Biosciences Ltd. (NASDAQ:TRPX) and Advaxis Inc. (NASDAQ:ADXS), are affected by compare. This especially applies to their dividends, analyst recommendations, profi Read more

Proudly made at

ROCKIT